MKI67 and osteosarcoma: Positive Ki-67 expression was demonstrated to be associated with stage, distant metastasis, and overall survival of osteosarcoma, thus implicating its potential as a biomarker to predict prognosis and guide clinical therapy for osteosarcoma [23].